Â鶹´«Ã½Ó³»­

Apply Giving
Resources for:
Students

Michael Rivner

Professor

Michael Rivner

Professor

Academic Appointment(s)

Medical College of Georgia
Department of Neurology

Emeritus Faculty

Medical College of Georgia
Department of Neuroscience and Regenerative Medicine

Administration
Department of The Graduate School

Bio

I am a specialist in Neuromuscular diseases. I established and run the ALS clinic. I have research grants in Myasthenia Gravis and ALS. I run the EMG lab at Wellstar MCG-Health. I also have an interest in botulinum toxins.

  • MRIVNER@augusta.edu
  • (706) 721-2681
  • (706) 721-8701
  • BP 4390

Education

  • MD, Medicine Emory University, 1978

  • BA, Psychology, General Duke University, 1972

  • BA, Zoology/Animal Biology Duke University, 1972

Certifications

  • DEA DEA, 2025

  • PHY GA Composite Medical Brd, 2025

  • South Carolina 1980

  • BLS American Heart Association, 2024

  • PHY GA Composite Medical Brd, 1979

  • BLS 2014

Awards & Honors

  • Lifetime Acheivement Award--2023 Â鶹´«Ã½Ó³»­, 2023

  • Outstanding Teacher of the Year 2015-2016 Department of Neurology, 2016

  • Clinical Science Teaching Award 2011 Medical College of Georgia, 2011

  • Neurology Department Outstanding Teacher of the year 2010 Neurology Department, 2010

  • Neurology Department Outstanding Teacher of the Year Neurology Department, 2006

Courses Taught Most Recent Academic Year

  • NEUR 5000

    Basic Clkshp in Neurology

  • RNEU 5004

    Clinical Neurophysiology

  • NEUR 5022

    EMG Elective

  • RNEU 5000

    Neurology

  • NEUR 5020

    Neuromuscular Disease

Teaching Interests

EMG, ALS, Myasthenia Gravis, Neuromuscular diseases, botulinum toxin

Scholarship

Selected Recent Publications

  • BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial, 2026
    Journal Article, Academic Journal
  • Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis, 2025
    Journal Article, Academic Journal
  • Safety and efficacy of trehalose in amyotrophic lateral sclerosis (HEALEY ALS Platform Trial): an adaptive, phase 2/3, double-blind, randomised, placebo-controlled trial, 2025
    Journal Article, Academic Journal
  • Efficacy and Safety of Autologous BCMA-directed mRNA CAR T-Cell Therapy in Generalized Myasthenia Gravis: Results from a Phase 2b Randomized Placebo-controlled Trial (S34.002), 2025
    Journal Article, Academic Journal
  • Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double-blind, placebo-controlled trial., 2025
    Journal Article, Academic Journal

Research Interests

EMG
ALS
Myasthenia Gravis
Botulinum Toxins

Department Service

  • EMG Lab 1983 - Present

    Role: Other

Professional Service

  • ALS Clinic 2007 - 2018

    Role: Director

  • EMG Lab 1983 - 2018

    Role: Director